Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23966556 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants
Conditions: Pertussis;   Diphtheria;   Tetanus;   Poliomyelitis;   Haemophilus Influenzae Type b
Interventions: Biological: DT5aP-IPV-Hib 5-component Pertussis vaccine;   Biological: Infanrix® -IPV+Hib

Indicates status has not been verified in more than two years